Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

LB03002: Phase III data

October 10, 2011 7:00 AM UTC

An open-label, international Phase III trial in 167 previously untreated children with GHD showed that expected height velocity growth rates were maintained during the second year of treatment in pati...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article